top of page
7.7 million patients annually, reducing keloid and hypertrophic scarring by up to 70%
Patient compliance to 85% compared to injection therapy
Home-based treatment can replace 12–24 clinic visits per year
Reduce surgeries and hospital stays, saving an estimated $2.8 billion in healthcare costs.
Dermaplex’s controlled microneedle delivery improves healing and cosmetic outcomes with less pain, reducing reliance on opioid painkillers. Its affordable, mass-producible design enables access for rural and underserved communities, while home-based treatment and real-time monitoring provide remote guidance and improve patient compliance.
bottom of page